Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex

M. Carrier; M. A. Rodger; D. Fergusson; S. Doucette; M. J. Kovacs; J. Moore; J. G. Kelton; G. A. Knoll

doi:10.1038/sj.ki.5002631

Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex

M. Carrier, M. A. Rodger, D. Fergusson, S. Doucette, M. J. Kovacs, J. Moore, J. G. Kelton, G. A. Knoll

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	213-219
页数	7
期刊	Kidney International
卷	73
期	2
DOI	https://doi.org/10.1038/sj.ki.5002631
出版状态	已出版 - 1月 10 2008
已对外发布	是

!!!ASJC Scopus Subject Areas

肾脏学

访问文件

10.1038/sj.ki.5002631

其它文件与链接

引用此

@article{92a4aa42128d45be882ee56cf3abe63a,

title = "Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex",

keywords = "Mortality, Mortality risk",

author = "M. Carrier and Rodger, {M. A.} and D. Fergusson and S. Doucette and Kovacs, {M. J.} and J. Moore and Kelton, {J. G.} and Knoll, {G. A.}",

note = "Funding Information: This work was supported by grant R05-28 from the Physician{\textquoteright} Services Incorporated Foundation. MAR is a recipient of the Maureen Andrew New Investigator Award from the Heart and Stroke Foundation of Canada. None of the authors have any conflict of interest to disclose. Dr GA Knoll had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. We thank the staff and patients from the dialysis units who participated in this study.",

year = "2008",

month = jan,

day = "10",

doi = "10.1038/sj.ki.5002631",

language = "English",

volume = "73",

pages = "213--219",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex

AU - Carrier, M.

AU - Rodger, M. A.

AU - Fergusson, D.

AU - Doucette, S.

AU - Kovacs, M. J.

AU - Moore, J.

AU - Kelton, J. G.

AU - Knoll, G. A.

N1 - Funding Information: This work was supported by grant R05-28 from the Physician’ Services Incorporated Foundation. MAR is a recipient of the Maureen Andrew New Investigator Award from the Heart and Stroke Foundation of Canada. None of the authors have any conflict of interest to disclose. Dr GA Knoll had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. We thank the staff and patients from the dialysis units who participated in this study.

PY - 2008/1/10

Y1 - 2008/1/10

KW - Mortality

KW - Mortality risk

UR - http://www.scopus.com/inward/record.url?scp=37549048977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549048977&partnerID=8YFLogxK

U2 - 10.1038/sj.ki.5002631

DO - 10.1038/sj.ki.5002631

M3 - Article

C2 - 17943076

AN - SCOPUS:37549048977

SN - 0085-2538

VL - 73

SP - 213

EP - 219

JO - Kidney International

JF - Kidney International

IS - 2

ER -

Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此